Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gareth R Evans

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Cancer Screening Recommendations for Individuals with Li-Fraumeni SyndromeChristian P Kratz, Maria Isabel Achatz, Laurence Brugières, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2023
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational studyRobert D Morgan, Andrew R Clamp, Bethany M Barnes, et al.
Human Mutation|October 6, 2009
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHDChristopher J Ricketts, Julia R Forman, Eleanor Rattenberry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II TrialRobert D Morgan, Andrew R Clamp, Daniel J White, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Ebiomedicine|October 21, 2019
Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestryYaohua Yang, Xiang Shu, Xiao-Ou Shu, et al.
Nature Genetics|October 26, 2010
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33Richard S Houlston, Jeremy Cheadle, Sara E Dobbins, et al.
Nature Genetics|April 1, 2008
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3Ian P M Tomlinson, Emily Webb, Luis Carvajal-Carmona, et al.
American Journal of Human Genetics|January 2, 2018
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848Magdalena Koczkowska, Yunjia Chen, Tom Callens, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Cancer Screening Recommendations for Individuals with Li-Fraumeni SyndromeChristian P Kratz, Maria Isabel Achatz, Laurence Brugières, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2023
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational studyRobert D Morgan, Andrew R Clamp, Bethany M Barnes, et al.
Human Mutation|October 6, 2009
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHDChristopher J Ricketts, Julia R Forman, Eleanor Rattenberry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II TrialRobert D Morgan, Andrew R Clamp, Daniel J White, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Ebiomedicine|October 21, 2019
Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestryYaohua Yang, Xiang Shu, Xiao-Ou Shu, et al.
Nature Genetics|October 26, 2010
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33Richard S Houlston, Jeremy Cheadle, Sara E Dobbins, et al.
Nature Genetics|April 1, 2008
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3Ian P M Tomlinson, Emily Webb, Luis Carvajal-Carmona, et al.
American Journal of Human Genetics|January 2, 2018
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848Magdalena Koczkowska, Yunjia Chen, Tom Callens, et al.
Pageof 11